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Accepted 6 February 2017; Published online 27 March 2017AbstractObjectives: The aim of the study was to extend a previously published checklist of study design features to include study designs often
used by health systems researchers and economists. Our intention is to help review authors in any field to set eligibility criteria for studies to
include in a systematic review that relate directly to the intrinsic strength of the studies in inferring causality. We also seek to clarify key
equivalences and differences in terminology used by different research communities.
Study Design and Setting: Expert consensus meeting.
Results: The checklist comprises seven questions, each with a list of response items, addressing: clustering of an intervention as an
aspect of allocation or due to the intrinsic nature of the delivery of the intervention; for whom, and when, outcome data are available;
how the intervention effect was estimated; the principle underlying control for confounding; how groups were formed; the features of a
study carried out after it was designed; and the variables measured before intervention.
Conclusion: The checklist clarifies the basis of credible quasi-experimental studies, reconciling different terminology used in different
fields of investigation and facilitating communications across research communities. By applying the checklist, review authors’ attention is
also directed to the assumptions underpinning the methods for inferring causality.  2017 The Authors. Published by Elsevier Inc. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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There are difficulties in drawing up a taxonomy of study
designs to evaluate health care interventions or systems that
do not use randomization [1]. To avoid the ambiguities of
study design labels, a checklist of design features has been
proposed by the Cochrane Non-Randomized Studies
Methods Group (including B.C.R. and G.A.W.) to classify
nonrandomized studies of health care interventions on the ba-
sis of what researchers did [1,2]. The checklist includes items
about: whether a study made a comparison and, if yes, how
comparison groups were formed; the timing of key elements
of a study in relation to its conduct; and variables compared
between intervention and comparator groups [1,2]. TheFunding: B.C.R is supported in part by the U.K. National Institute for
Health Research Bristol Cardiovascular Biomedical Research Unit. H.W.
is supported by 3ie.
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0895-4356/ 2017 The Authors. Published by Elsevier Inc. This is an open acc
licenses/by-nc-nd/4.0/).checklist was created primarily from the perspective of health
care evaluation, that is, the kinds of intervention most
commonly considered in Cochrane reviews of interventions.
The checklist works well in principle for study designs
in which the allocation mechanism applies to individual
participants, although it does not characterize unit of anal-
ysis issues that may arise from the mechanism of allocation
or the organizational hierarchy through which an interven-
tion is provided (clustering by practitioner or organizational
unit on which allocation is based), unit of treatment issues
arising from the organizational hierarchy through which the
intervention is provided, or unit of analysis issues arising
from the unit at which data are collected and analysed
(whether patient, practitioner or organisational aggregate).
Most health interventions are delivered by discrete care
provider units, typically organized hierarchically (e.g., hos-
pitals, family practices, practitioners); this makes clustering
important, except when allocation is randomized, because
interventions are chosen by care provider units in complexess article under the CC BY-NC-ND license (http://creativecommons.org/
31inical Epidemiology 89 (2017) 30e42What is new?
 Evaluations of health system interventions have
features that differ and which are described differ-
ently compared to evaluations of health care
interventions.
 An existing checklist of features has been extended
to characterize: nesting of data in organizational
clusters, for example, service providers; number
of outcome measurements and whether outcomes
were measured in the same or different individuals;
whether the effects of an intervention are estimated
by change over time or between groups; and the
intrinsic ability of the analysis to control for
confounding.
 Evaluations of health care and health system inter-
ventions have features that affect their credibility
with respect to establishing causality but which
are not captured by study design labels.
 With respect to inferring causality, review authors
need to consider these features to discriminate
‘‘strong’’ from ‘‘weak’’ designs.
 Review authors can define eligibility criteria for a
systematic review with reference to these study
design features, but applying the checklist does
not obviate the need for a careful risk of bias
assessment.
B.C. Reeves et al. / Journal of Clways. A modified checklist was also suggested for cluster-
allocated designs (diverse study designs in which the allo-
cation mechanism applies to groups of participants) [1,2],
often used to evaluate interventions applied at the level of
the group (e.g., disease prevention, health education, health
policy), but the authors acknowledged that this checklist
had not been well piloted.
There are three key challenges when trying to communi-
cate study designs that do not use randomization to evaluate
the effectiveness of interventions. First, study design labels
are diverse or ambiguous, especially for cluster-allocated
designs; moreover, there are key differences between
research fields in the way that similar designs are
conceived. Second, some study designs are, in fact, strate-
gies for analysis rather than designs per se. Terms such as
quasi-experimental, natural experiment, and observational
cause particular ambiguity. The current checklist does not
explicitly consider designs/analyses commonly used in
health systems research (including so-called ‘‘credible
quasi-experimental studies’’ [3,4]), often taking advantage
of large administrative or other available data sets, and in
other cases using data purposely collected as part ofprospective designs where random assignment is not
feasible. Third, and important with respect to the motiva-
tion for this paper, differences of opinion exist between
health care and health systems researchers about the extent
to which some studies are ‘‘as good as’’ randomized trials
when well conducted; it is not clear whether this is because
common designs are described with different labels or
whether there are substantive differences. Therefore, our
primary aim in this paper is revise the checklist to over-
come these limitations.
Specific objectives were (1) to include a question to cap-
ture information about clustering; and (2) to extend the
checklist to include study designs often used by health sys-
tems researchers and econometricians in a way that deals
with the design/analysis challenge. We intended that the
revised checklist should be able to resolve the differences
in opinion about the extent to causality can be inferred from
nonrandomized studies with different design features,
improving communication between different health
research communities. We did not intend that the checklist
should be used as a tool to assess risk of bias, which can
vary across studies with the same design features.
The paper is structured in three parts. Part 1 sets out de-
signs currently used for health systems evaluations, illus-
trating their use through inclusion of different designs/
analyses in a recent systematic review. Part 2 describes de-
signs used for health intervention/program evaluations. Part
3 clarifies some of the ambiguities of study design labels
using the proposed design feature framework.2. Part 1: ‘‘quasi-experimental’’ studies considered by
health system researchers and health economists
Health systems researchers and health economists use a
wide range of ‘‘quasi-experimental’’ approaches to estimate
causal effects of health care interventions. Some methods
are considered stronger than others in estimating an unbi-
ased causal relationship. ‘‘Credible quasi-experimental
studies’’ are ones that ‘‘estimate a causal relationship using
exogenous variation in the exposure of interest which is not
usually directly controlled the researcher.’’ This exogenous
variation refers to variation determined outside the system
of relationships that are of interest and in some situations
may be considered ‘‘as good as random’’ variation [3e5].
Credible quasi-experimental approaches are based on
assignment to treatment and control that is not controlled
by the investigators, and the term can be applied to different
assignment rules; allocation to treatment and control is by
definition not randomized, although some are based on
identifying a source of variation in an exposure of interest
that is assumed to be random (or exogenous). In the present
context, they are considered to use rigorous designs and
methods of analysis which can enable studies to adjust
for unobservable sources of confounding [6] and are
32 B.C. Reeves et al. / Journal of Clinical Epidemiology 89 (2017) 30e42identical to the union of ‘‘strong’’ and ‘‘weak’’ quasi-
experiments as defined by Rockers et al. [4].
Credible quasi-experimental methods use assignment
rules which are either known or can be modeled statisti-
cally, including: methods based on a threshold on a contin-
uous scale (or ordinal scale with a minimum number of
units) such as a test score (regression discontinuity design)Box 1 Thumbnail sketches of quasi-experimental studies
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ference studies [including difference in differences, (DIDs)]
and, to a lesser extent, propensity score matching (PSM)
where individuals or groups are matched on preexisting
characteristics measured at baseline and interrupted time
series (ITS). Thumbnail sketches of these and other designs
used by health system researchers are described in Box 1. It
should be noted that the sketches of study types used by
health program evaluators are not exhaustive. For example,
pipeline studies, where treatment is withheld temporarily in
one group until outcomes are measured (where time of
treatment is not randomly allocated), are also used.
Quasi-experimental methods are used increasingly to
evaluate programs in health systems research. Gaarder
et al. [11], Baird et al. [12], and Kabeer and Waddington
[13] have published reviews incorporating quasi-
experimental studies on conditional cash transfer
(CCT) programs, which make welfare benefits condi-
tional upon beneficiaries taking specified actions like
attending a health facility during the pre/post-natal
period or enrolling children in school. Other reviews
including quasi-experimental studies have evaluated
health insurance schemes [14, 15] and maternal and child
health programs [16]. Other papers in this themed issue
of the Journal of Clinical Epidemiology describe how
quasi-experimental studies can be identified for evidence
synthesis [17], how data are best collected from quasi-
experimental studies [18], and how the global capacity
for including quasi-experimental studies in evidence syn-
thesis can best be expanded [19, 20]. In this paper, we
use studies from the reviews on the effects of CCT pro-
grams to illustrate the wide range of quasi-experimental
methods used to quantify causal effects of the programs
(Table 1).
Some of the earliest CCT programs randomly assigned
clusters (communities of households) and used longitudinal
household survey data collected by researchers to estimate
the effects of CCTs on the health of both adults andTable 1. Experimental and quasi-experimental approaches applied in studie
Study design label Method of analysis
Randomized assignment Bivariate (means comparison), multivariable
regression
Regression discontinuity
design
Regression analysis
Instrumental variables regression (‘‘fuzzy’’
discontinuity)
Natural experiment Instrumental variables (e.g., two-stage least sq
regression analysis
Interrupted time series Time-series regression analysis
Difference study Difference-in-differences (DID) regression ana
Triple differences (DDD) regression analysis
Cohort study Propensity score matching (PSM), retrospectiv
cohort
Cross-sectional study Propensity score matching (PSM), regression a
Sources: reviews of CCTS by Gaarder et al. [11], Baird et al. [12] and Kabchildren [21]. The design and analysis of a cluster-
randomized controlled trial of this kind is familiar to health
care researchers [29].
In other cases, it was not possible to assign beneficiaries
randomly. In Jamaica’s PATH program [22], benefits were
allocated to people with scores below a criterion level on
a multidimensional deprivation index and the effects of
the program were estimated using a regression disconti-
nuity analysis. This study involved recruiting a cohort of
participants being considered for benefits, to whom a policy
decision was applied (i.e., assign benefits or not on the ba-
sis the specified deprivation threshold). In such studies, by
assigning the intervention on the basis of a cutoff value for
a covariate, the assignment mechanism (usually correlated
with the outcome of interest) is completely known and
can provide a strong basis for inferences, although usually
in a less efficient manner than in randomized controlled tri-
als (RCTs). The treatment effect is estimated as the differ-
ence (‘‘discontinuity’’) between two predictions of the
outcome based on the covariate (the average treatment ef-
fect at the cutoff): one for individuals just above the covar-
iate cutoff (control group) and one for individuals just
below the cutoff (intervention group) [30]. The covariate
is often a test score (e.g., to decide who receives a health
or education intervention) [31] but can also be distance
from a geographic boundary [32]. Challenges of this design
are assignment determined approximately, but not
perfectly, by the cutoff [33] or circumstances in which par-
ticipants may be able to control factors determining their
assignment status such as their score or location.
As with health care evaluation, many studies in health
systems research combine multiple methods. In Ecuador’s
Bono de Desarrollo Humano program, leakages in
implementation caused ineligible families to receive the
program, compromising the original discontinuity assign-
ment. To compensate for this problem, the effects of the
program were estimated as a ‘‘fuzzy discontinuity’’ using
IVE [23]. An instrument (in this case, a dichotomouss evaluating the effects of conditional cash transfer (CCT) programs
CCT program example
PROGRESSA, Mexico [21]
Programme of Advancement Through Health and
Education (PATH), Jamaica [22]
Bono de Desarrollo Humano (BDH), Ecuador [23]
uares) Bolsa Alimentac¸~ao, Brazil [9]
Safe Delivery Incentive Programme (SDIP), Nepal [24]
lysis Familias en Accion, Colombia [25]
Cambodia Education Sector Support Project (CESSP)
[26]
e Tekopor~a, Paraguay [27]
nalysis Bolsa Familia, Brazil [28]
eer and Waddington [13].
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the participating family had a value on a proxy means test
below or above a cutoff value used to determine eligibility
to the program) must be associated with the assignment of
interest, unrelated to potential confounding factors and
related to the outcome of interest only by virtue of the rela-
tionship with the assignment of interest (and not, e.g., eligi-
bility to another program which may affect the outcome of
interest). If these conditions hold, then an unbiased effect of
assignment can be estimated using two-stage regression
methods [10]. The challenge lies not in the analysis itself
(although such analyses are, typically, inefficient) but in
demonstrating that the conditions for having a good instru-
ment are met.
In the case of Bolsa Alimentac¸~ao in Brazil, a computer
error led eligible participants whose names contained
nonstandard alphabetical characters to be excluded from
the program. Because there are no reasons to believe that
these individuals would have had systematically different
characteristics to others, the exclusion of individuals was
considered ‘‘as good as random’’ (i.e., a true natural exper-
iment based on quasi-random assignment) [9].
Comparatively few studies in this review used ITS estima-
tion, and we are not aware of any studies in this literature
which have been able to draw on sufficiently long time series
with longitudinal data for individual units of observation in
order for the design to qualify ‘‘as good as randomized.’’
An evaluation of Nepal’s Safe Delivery Incentive Pro-
gramme (SDIP) drew on multiple cohorts of eligible house-
holds before and after implementation over a 7-year period
[24]. The outcome (neonatal mortality) for each household
was available at points in time that could be related to the
inception of the program. Unfortunately, comparison group
data were not available for nonparticipants, so an analysis
of secular trends due to general improvements in maternal
and child health care (i.e., not due to SDIP) was not possible.
However, the authors were able to implement a regression
‘‘placebo test’’ (sometimes called a ‘‘negative control’’), in
which SDIP treatment was linked to an outcome (use of ante-
natal care) which was not expected to be affected by the pro-
gram, the rationale being that the lack of an estimated spike in
antenatal care at the time of the expected change in mortality
might suggest that these other confounding factors were not
at play. But ultimately, due to the lack of comparison group
data, the authors themselves note that the study is only able
to provide ‘‘plausible evidence of an impact’’ rather than
probabilistic evidence (p. 224).
Individual-level DID analyses use participant-level
panel data (i.e., information collected in a consistent
manner over time for a defined cohort of individuals).
The Familias en Accion program in Colombia was evalu-
ated using a DID analysis, where eligible and ineligible
administrative clusters were matched initially using propen-
sity scores. The effect of the intervention was estimated as
the difference between groups of clusters that were or were
not eligible for the intervention, taking into account thepropensity scores on which they were matched [25]. DID
analysis is only a credible method when we expect unob-
servable factors which determine outcomes to affect both
groups equally over time (the ‘‘common trends’’ assump-
tion). In the absence of common trends across groups, it
is not possible to attribute the growth in the outcome to
the program using the DID analysis. The problem is that
we rarely have multiple period baseline data to compare
variation between groups in outcomes over time before im-
plementation, so the assumption is not usually verifiable. In
such cases, placebo tests on outcomes which are related to
possible confounders, but not the program of interest, can
be investigated (see also above). Where multiple period
baseline data are available, it may be possible to test for
common trends directly and, where common trends in
outcome levels are not supported, undertake a ‘‘differ-
ence-in-difference-in-differences’’ (DDDs) analysis. In
Cambodia, the evaluators used DDD analysis to evaluate
the Cambodia Education Sector Support Project, over-
coming the observed lack of common trends in preprogram
outcomes between beneficiaries and nonbeneficiaries [26].
As in the case of Attanasio et al. above [25], difference
studies are usually made more credible when combined
with methods of statistical matching because such studies
are restricted to (or weighted by) individuals and groups
with similar probabilities of participation based on
observed characteristicsdthat is, observations ‘‘in the re-
gion of common support.’’ However, where panel or multi-
ple time series cohort data are not available, statistical
matching methods are often used alone. By contrast with
the above examples, a conventional cohort study design
was used to evaluate Tekopor~a in Paraguay, relying on
PSM and propensity weighted regression analysis of bene-
ficiaries and nonbeneficiaries at entry into the cohort to
control for confounding [27]. Similarly, for Bolsa Familia
in Brazil evaluators applied PSM to cross-sectional
(census) data [28]. Variables used to match observations
in treatment and comparison should not be determined by
program participation and are therefore best collected at
baseline. However, this type of analysis alone does not
satisfy the criterion of enabling adjustment for unobserv-
able sources of confounding because it cannot rule out con-
founding of health outcomes data by unmeasured
confounding factors, even when participants are well char-
acterized at baseline.3. Part 2: ‘‘quasi-experimental’’ designs used by
health care evaluation researchers
The term ‘‘quasi-experimental’’ is also used by health
care evaluation and social science researchers to describe
studies in which assignment is nonrandom and influenced
by the researchers. At the first appearance, many of the de-
signs seem similar, although they are often labeled differ-
ently. Although an assignment rule may be known, it may
Box 2 Thumbnail sketches of quasi-experimental study designs used by health care evaluation researchers
Studies are cited which correspond to the way in which we conceive studies described with these labels.
Randomized controlled
trial (RCT)
Individual participants, or clusters of participants, are randomly allocated to intervention or
comparator. This design is the same as the RCT design described in Box 1.
Quasi-randomized
controlled trial
(Q-RCT)
Individual participants, or clusters of participants, are allocated to intervention or comparator in a
quasi-random manner. In health care evaluation studies, the allocation rule is often by alternation,
day of the week, odd/even hospital, or social security number [39]. The allocation rule may be as
good as random but, typically, gives rise to a less credible study (compared to health system
studies, where the allocation rule is applied by a higher level decision maker); if allocation is not
concealed, research personnel who know the rule can recruit selectively or allocate participants in
a biased way. This design is essentially the same as the Q-RCT design described in Box 1 but
with different mechanisms for allocation.
Controlled before-and-after
study (CBA)
Study in which outcomes are assessed at two time periods for several clusters (usually geographic).
Clusters are classified into intervention and comparator groups. All clusters are studied without
the intervention during period 1. Between periods 1 and 2, clusters in the intervention group
implement the intervention of interest whereas clusters in the comparator group do not. The
outcome for clusters receiving the intervention is compared to the outcome for comparator
clusters during period 2, adjusted for the outcomes observed during period 1 (when no clusters
had had the intervention). Observations usually represent episodes of care, so may or may not
correspond to the same individuals during the two time periods. Data at either an aggregate [40]
or individual level [41] can be analyzed. This design has similarities to the DID design described
in Box 1.
Nonrandomized controlled
trial (NRCT)
This is usually a prospective cohort study in which allocation to intervention and comparator is not
random or quasi-random and is applied by research personnel [42]. The involvement of research
personnel in the allocation rule may be difficult to discern; such studies may be labeled
observational if the personnel responsible for the allocation rule are not clearly described or some
personnel have both health care decision making and researcher roles. Individual-level data are
usually analyzed. Note that nonrandom allocation of a health care intervention is often defined in
relation to organizational factors (ward, clinic, doctor, provider organization) [43], and the
analysis should take account of the data hierarchy if one exists.
Interrupted time series
(ITS)
When used to study health care interventions, observations usually represent episodes of care or
events, the cohorts studied may or may not correspond to the same individuals at different time
points and are often clustered in organizational units (e.g., a health facility or district). (Such
studies may be considered to consist of multiple cross-sectional ‘‘snapshots.’’) The analysis may
be aggregated at the level of the clusters [44] or at the level of individual episodes of care [45]. If
ITS do not have the benefit of analyzing multiple measurements from the same cohort over time
(Box 1), confounding by secular trends needs to be assessed, for example, with reference to a
contemporaneous comparison group (controlled interrupted time series, CITS, below). NB.
Entries in Table 2 are for ITS as defined in Box 1; for ITS as defined here, entries for some cells
would change. This design is similar to the ITS design described in Box 1.
Controlled interrupted
time series (CITS)
As above for an ITS but with data for a contemporaneous comparison group in which the
intervention was not implemented [46]. Measurements for the comparison group should be
collected using the same methods. This design is similar to the CITS design described in Box 1.
Concurrently controlled
prospective cohort
study (PCS)
A cohort study in which subjects are identified prospectively and classified as having received the
intervention or comparator of interest on the basis of the prospectively collected information [47].
Data for individuals are usually analyzed. However, it is important to note that nonrandom receipt
of a health care intervention is almost always defined in relation to organizational factors (ward,
clinic, doctor, provider organization), and the analysis should take into account the data hierarchy.
This is equivalent to a ‘‘pipeline design’’ used in health systems program evaluation. It is very
similar to a NRCT, except with respect to the method of allocation.
Concurrently controlled
retrospective cohort
study (RCS)
A cohort study in which subjects are identified from historic records and classified as having
received the intervention or comparator of interest on the basis of the historic information [48].
As for a PCS, data for individuals are usually analyzed, but the analysis should take account of
the data hierarchy.
Historically controlled
cohort study (HCS)
This type of cohort study is a combination of an RCS (for one group, usually receiving the
comparator) and a PCS (for the second group, usually receiving the intervention) [49]. Thus, the
comparison between groups is not contemporaneous. The analysis should take into account the
data hierarchy.
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Caseecontrol
study (CC)
Consecutive individuals experiencing an outcome of interest are identified, preferably
prospectively, from within a defined population (but for whom relevant data have not been
collected) and form a group of ‘‘cases’’ [50]. Individuals, sometimes matched to the cases, who
did not experience the outcome of interest are also identified from within the defined population
and form the group of ‘‘controls.’’ Data characterizing the intervention or comparator received in
the past are collected retrospectively from existing records or by interviewing participants. The
receipt of the intervention or comparator of interest is compared among cases and controls. If
applicable, the analysis should take into account the data hierarchy.
Nested casee
control study (NCC)
Individuals experiencing an outcome of interest are identified from within a defined cohort (for
which some data have already been collected) and form a group of ‘‘cases.’’ Individuals, often
matched to the cases, who did not experience the outcome of interest are also identified from
within the defined cohort and form the group of ‘‘controls’’ [51]. Additional data required for the
study, characterizing the intervention or comparator received in the past, are collected
retrospectively from existing records or by interviewing participants. The receipt of the
intervention or comparator of interest is compared among cases and controls. If applicable, the
analysis should take into account the data hierarchy.
Before after
study (BA)
As for CBA but without data for a control group of clusters [52]. An uncontrolled comparison is
made between frequencies of outcomes for the two time points.
This term may also be applied to a study in which a cohort of individuals have the outcome (e.g.,
function, symptoms, or quality of life) measured before an intervention and after the intervention
[53]. This type of study comprises a single ‘‘exposed’’ cohort [54] (often called a ‘‘case series’’),
with the outcome measured before and after exposure. If applicable, the analysis should take into
account the data hierarchy.
Cross-sectional
study (XS)
The feature of this study design is that information required to classify individuals according to
receipt of the intervention or comparator of interest and according to outcome are collected at the
same time, sometimes preventing researchers from knowing whether the intervention preceded
the outcome [55]. In cross-sectional studies of health interventions, despite collecting data about
the intervention/comparator and outcome at one point in time, the nature of the intervention and
outcome may allow one to be confident about whether the intervention preceded the outcome.
This design is similar to the XS design described in Box 1.
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system evaluations; for example, quasi-random allocation
may be biased because of a lack of concealment, even when
the allocation rule is ‘‘as good as random.’’
Researchers also use more conventional epidemiological
designs, sometimes called observational, that exploit natu-
rally occurring variation. Sometimes, the effects of inter-
ventions can be estimated in these cohorts using
instrumental variables (prescribing preference; surgical vol-
ume; geographic variation, distance from health care facil-
ity), quantifying the effects of an intervention in a way that
is considered to be unbiased [34e36]. Instrumental variable
estimation using data from a randomized controlled trial to
estimate the effect of treatment in the treated, when there is
substantial nonadherence to the allocated intervention, is a
particular instance of this approach [37,38].
Nonrandomized study design labels commonly used by
health care evaluation researchers include: nonrandomized
controlled trial, controlled before-and-after study (CBA),
interrupted time series study (ITS; and CITS), prospective,
retrospective or historically controlled cohort studies (PCS,
RCS and HCS respectively), nested caseecontrol study,
caseecontrol study, cross-sectional study, and before-after
study. Thumbnail sketches of these study designs are givenin Box 2. In addition, researchers sometimes report findings
for uncontrolled cohorts or individuals (‘‘case’’ series or re-
ports), which only describe outcomes after an intervention
[54]; these are not considered further because these studies
do not collect data for an explicit comparator. It should be
noted that these sketches are the authors’ interpretations of
the labels; studies that other researchers describe using
these labels may not conform to these descriptions.
The designs can have diverse features, despite having
the same label. Particular features are often chosen to
address the logistical challenges of evaluating particular
research questions and settings. Therefore, it is not possible
to illustrate them with examples drawn from a single review
as in part 1; instead, studies exemplifying each design are
cited across a wide range of research questions and settings.
The converse also occurs, that is, study design labels are
often inconsistently applied. This can present great diffi-
culties when trying to classify studies, for example, to
describe eligibility for inclusion in a review. Relying on
the study design labels used by primary researchers them-
selves to describe their studies can lead to serious
misclassifications.
For some generic study designs, there are distinct study
types. For example, a cohort study can study intervention
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about the intervention and comparator collected prospec-
tively (PCS) or retrospectively (RCS), or study one group
retrospectively and the other group prospectively (HCS).
These different kinds of cohort study are conventionally
distinguished according to the time when intervention and
comparator groups are formed, in relation to the conception
of the study. Some studies are sometimes incorrectly
termed PCS, in our view, when data are collected prospec-
tively, for example, for a clinical database, but when defini-
tions of intervention and comparator required for the
evaluation are applied retrospectively; in our view, this
should be an RCS.4. Part 3: study design features and their role in
disambiguating study design labels
Some of the study designs described in parts 1 and 2
may seem similar, for example, DID and CBA, although
they are labeled differently. Some other study design la-
bels, for example, CITS/ITS, are used in both types of
literature. In our view, these labels obscure some of the
detailed features of the study designs that affect the
robustness of causal attribution. Therefore, we have
extended the checklist of features to highlight these
differences. Where researchers use the same label to
describe studies with subtly different features, we do not
intend to imply that one or other use is incorrect; we
merely wish to point out that studies referred to by the
same labels may differ in ways that affect the robustness
of an inference about the causal effect of the intervention
of interest.
The checklist now includes seven questions (Table 2).
The table also sets out our responses for the range of study
designs as described in Boxes 1 and 2. The response
‘‘possibly’’ (P) is prevalent in the table, even given the de-
scriptions in these boxes. We regard this as evidence of the
ambiguity/inadequate specificity of the study design labels.
Question 1 is new and addresses the issue of clustering,
either by design or through the organizational structure
responsible for delivering the intervention (Box 3). This
question avoids the need for separate checklists for designs
based on assigning individual and clusters. A ‘‘yes’’
response can be given to more than one response item;
the different types clustering may both occur in a single
study and implicit clustering can occur an individually allo-
cated nonrandomized study.
Question 1 in the checklist distinguishes individual allo-
cation, cluster allocation (explicit clustering), and clus-
tering due to the organizational hierarchy involved in the
delivery of the interventions being compared (implicit clus-
tering). Users should respond factually, that is, with respect
to the presence of clustering, without making a judgment
about the likely importance of clustering (degree of depen-
dence between observations within clusters).Questions 2e4 are also new, replacing the first question
(‘‘Was there a relevant comparison?’’) in the original
checklist [1,2]. These questions are designed to tease apart
the nature of the research question and the basis for infer-
ring causality.
Question 2 classifies studies according to the number of
times outcome assessments were available. In each case,
the response items distinguish whether or not the outcome
is assessed in the same or different individuals at different
times. Only one response item can be answered ‘‘yes.’’
Treatment effects can be estimated as changes over time
or between groups. Question 3 aims to classify studies ac-
cording to the parameter being estimated. Response items
distinguish changes over time for the same or different in-
dividuals. Only one response item can be answered ‘‘yes.’’
Question 4 asks about the principle through which the
primary researchers aimed to control for confounding.
Three response items distinguish methods that:
a. control in principle for any confounding in the
design, that is, by randomization, IVE, or regression
discontinuity;
b. control in principle for time invariant unobserved
confounding, that is, by comparing differences in
outcome from baseline to end of study, using longitu-
dinal/panel data for a constant cohort; or
c. control for confounding only by known and observed
covariates (either by estimating treatment effects in
‘‘adjusted’’ statistical analyses or in the study design
by restricting enrollment, matching and/or stratified
sampling on known, and observed covariates).
The choice between these items (again, only one can be
answered ‘‘yes’’) is key to understanding the basis for infer-
ring causality.
Questions 5e7 are essentially the same as in the orig-
inal checklist [1,2]. Question 5 asks about how groups
(of individuals or clusters) were formed because treatment
effects are most frequently estimated from between group
comparisons. An additional response option, namely by a
forcing variable, has been included to identify credible
quasi-experimental studies that use an explicit rule for
assignment based on a threshold for a variable measured
on a continuous or ordinal scale or in relation to a spatial
boundary. When answering ‘‘yes’’ to this item, the review
author should also identify the nature of the variable by
answering ‘‘yes’’ to another item. Possible assignment
rules are identified: the action of researchers, time differ-
ences, location differences, health care decision makers/
practitioners, policy makers, on the basis of the outcome,
or some other process. Other, nonexperimental, study de-
signs should be classified by the method of assignment
(same list of variables) but without there being an explicit
assignment rule.
Question 6 asks about important features of a study in rela-
tion to the timing of their implementation. Studies are
Table 2. Quasi-experimental taxonomy features checklist
RCT Q-RCT IV RD CITS ITS DID CBA NRCT PCS RCS HCT NCC CC XS BA
1. Was the intervention/comparator:
(answer ‘‘yes’’ to more than 1
item, if applicable)
Allocated to (provided for/
administered to/chosen by)
individuals?
P P Y Y P P P P P P P P Y Y P P
Allocated to (provided for/
administered to/chosen by)
clusters of individuals?a
P P N N P P P P P P P P N N P P
Clustered in the way it was provided
(by practitioner or organizational
unit)?b
P P P P P P P P P P P P P P P P
2. Were outcome data available:
(answer ‘‘yes’’ to only 1 item)
After intervention/comparator only
(same individuals)?
P P P P N N N N P P P P Y Y Y N
After intervention/comparator only
(not all same individuals)?
N N N N P P N P P P P P N N N P
Before (once) AND after
intervention/comparator (same
individuals)?
P P P P N N N P P P P P N N P Y
Before (once) AND after
intervention/comparator (not all
same individuals)?
N N N N P P P P P P P P N N N P
Multiple times before AND multiple
times after intervention/
comparator (same individuals)?
P P P P P P P P P P P P N N P P
Multiple times before AND multiple
times after intervention/
comparator (not all same
individuals)?
N N N N P P P P N N N N N N N N
3. Was the intervention effect
estimated by: (answer ‘‘yes’’ to
only one item)
Change over time (same individuals
at different time points)?
N N N N N Y N N N N N N N N N P
Change over time (not all same
individuals at different time
points)?
N N N N N Y N N N N N N N N N P
Difference between groupsc (of
individuals or clusters receiving
either intervention or
comparator)?
Y Y Y Y Y N Y Y Y Y Y Y Y Y Y N
4. Did the researchers aim to control
for confounding (design or
analysis) (answer ‘‘yes’’ to only
one item)
Using methods that control in
principle for any confounding?
Y Y Y Y Y Y N N N N N N N N N N
Using methods that control in
principle for time-invariant
unobserved confounding?
N N N N N N Y Y N N N N N N N N
Using methods that control only for
confounding by observed
covariates?
P P P P P P P P Y Y Y Y Y Y Y N
5. Were groups of individuals or
clusters formed by (answer ‘‘yes’’
to more than one item, if
applicable)e
Randomization? Y N N N N na N N N N N N N N N na
Quasi-randomization? N Y N N N na N N N N N N N N N na
(Continued)
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Table 2. Continued
RCT Q-RCT IV RD CITS ITS DID CBA NRCT PCS RCS HCT NCC CC XS BA
Explicit rule for allocation based on
a threshold for a variable
measured on a continuous or
ordinal scale or boundary (in
conjunction with identifying the
variable dimension, below)?
N N Y Y N na N N N N N N N N N na
Some other action of researchers? N N P P P na N N Y P P P N N N na
Time differences? N N N N Y na N N N N N Y N N N na
Location differences? N N P P P na P P P P P P N N P na
Health care decision makers/
practitioners?
N N P P P na P P P P P P N N P na
Participants’ preferences? N N P N N na P P P P P P N N P na
Policy maker N N P P P na P P P P P P N N P na
On the basis of outcome?d N N N N N na N N N N N N Y Y N na
Some other process? (specify) N N P P P na P P P P P P N N P na
6. Were the following features of the
study carried out after the study
was designed (answer ‘‘yes’’ to
more than one item, if applicable)
Characterization of individuals/
clusters before intervention?
Y Y P P P P P P Y Y P P N N N P
Actions/choices leading to an
individual/cluster becoming a
member of a group?d
Y Y P P P na P P Y Y P P N N N na
Assessment of outcomes? Y Y P P P P P P Y Y P P P P N P
7. Were the following variables
measured before intervention:
(answer ‘‘yes’’ to more than one
item, if applicable)
Potential confounders? P P P P P N P P P P P P P P N N
Outcome variable(s)? P P P P Y Y Y Y P P P P N N N P
Abbreviations: RCT, randomized controlled trial; Q-RCT, quasi-randomized controlled trial; IV, instrumental variable; RD, regression disconti-
nuity; CITS, controlled interrupted time series; ITS, interrupted time series; DID, difference-in-difference; CBA, controlled before-and-after study;
NRCT, nonrandomized controlled trial; PCS, prospective cohort study; RCS, retrospective cohort study; HCT, historically controlled study; NCC,
nested caseecontrol study; CC, caseecontrol study; XS, cross-sectional study; BA, before-after study; Y, yes; N, no; P, possibly; na, not applicable.
Cells in the table are completed with respect to the thumbnail sketches of the corresponding designs described in Boxes 1 and 2.
a This row describes ‘‘explicit’’ clustering. In randomized controlled trials, participants can be allocated individually or by virtue of ‘‘belonging’’
to a cluster such as a primary care practice or a village.
b This row describes ‘‘implicit’’ clustering. In randomized controlled trials, participants can be allocated individually but with the intervention
being delivered in clusters (e.g., group cognitive therapy); similarly, in a cluster-randomized trial (by general practice), the provision of an inter-
vention could also be clustered by therapist, with several therapists providing ‘‘group’’ therapy.
c A study should be classified as ‘‘yes’’ for this feature, even if it involves comparing the extent of change over time between groups.
d For (nested) caseecontrol studies, group refers to the case/control status of an individual.
e The distinction between these options is to do with the exogeneity of the allocation, hence designs further to the right in the table are more to
have involve allocation by some non-exogenous agent.
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out after the study was designed, namely: acquisition of
source data to characterize individuals/clusters before inter-
vention; actions or choices leading to an individual or cluster
becoming a member of a group; and the assessment of out-
comes. One or more of these items can be answered ‘‘yes,’’
as would be the case for all steps in a conventional RCT.
Question 7 asks about thevariables thatweremeasured and
available to control for confounding in the analysis. The two
broad classes of variables that are important are the identifica-
tion and collection of potential confounder variables andbase-
line assessment of the outcome variable(s). The answers to
this question will be less important if the researchers of the
original study used a method to control for any confounding,
that is, used a credible quasi-experimental design.The health care evaluation community has historically
been much more difficult to win around to the potential
value of nonrandomized studies to evaluate interventions.
We think that the checklist helps to explain why, that is,
because designs used in health care evaluation do not often
control for unobservables when the study features are
examined carefully. To the extent that these features are
immutable, the skepticism is justified. However, to the
extent that studies may be possible with features that pro-
mote the credibility of causal inference, health care evalu-
ation researchers may be missing an opportunity to provide
high-quality evidence.
Reflecting on the circumstances of nonrandomized evalua-
tions of health care and health system interventions may pro-
vide some insights why these different groups have disagreed
Box 3 Clustering in studies evaluating the effects of health system or health care interventions
Clustering is a potentially important consideration in both RCTs and nonrandomized studies. Clusters exist when
observations are nested within higher level organizational units or structures for implementing an intervention or data
collected; typically, observations within clusters will be more similar with respect to outcomes of interest than obser-
vations between clusters. Clustering is a natural consequence of many methods of nonrandomized assignment/desig-
nation because of the way in which many interventions are implemented. Analyses of clustered data that do not
take clustering into account will tend to overestimate the precision of effect estimates.
Clustering occurs when implementation of an intervention is explicitly at the level of a cluster/organizational unit (as
in a cluster-randomized controlled trial, in which each cluster is explicitly allocated to control or intervention). Clus-
tering can also arise implicitly, from naturally occurring hierarchies in the data set being analyzed, that reflect clusters
that are intrinsically involved in the delivery of the intervention or comparator. Both explicit and implicit clustering can
be present in a single study.
Examples of types of cluster
 Practitioner (surgeon; therapist, family doctor; teacher; social worker; probation officer; etc.).
 Organizational unit [general practice, hospital (ward), community care team; school, etc.].
 Social unit (family unit; network of individuals clustered in some nongeographic network, etc.).
 Geographic area (health region; city jurisdiction; small electoral district, etc.).
‘‘Explicit’’ clustering
 Clustering arising from allocation/formation of groups; clusters can contain only intervention or control
observations.
‘‘Implicit’’ clustering
 Clustering arising from naturally occurring hierarchies of units of analysis in the data set being analyzed to answer
the research question.
 Clusters can contain intervention and control observations in varying proportions.
 Factors associated with designation as intervention or control may vary by cluster.
No clustering
 Designation of an observation as intervention or control is only influenced by the characteristics of the observation
(e.g., patient choice to self-medicate with an over-the-counter medication; natural experiment in which allocation of
individuals is effectively random, as in the case of Bolsa Alimentac¸~ao where a computer error led to the allocation to
intervention or comparator [31].)
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studies. The checklist shows that credible quasi-experimental
studies gain credibility from using high-quality longitudinal/
panel data; such data characterizing health care are rare, leading
to evaluations that ‘‘make do’’with the data that are available in
existing information systems.
The risk of confounding in health care settings is inher-
ently greater because participants’ characteristics are
fundamental to choices about interventions in usual care;
mitigating against this risk requires high-quality clinical
data to characterize participants at baseline and, for
pharmaco-epidemiological studies about safety, often over
time. Important questions about health care for which
quasi-experimental methods of evaluation are typically
considered are often to do with the outcome of discrete ep-
isodes of care, usually binary, rather than long-term out-
comes for a cohort of individuals; this can lead to a focus
on the invariant nature of the organizations providing thecare rather than the varying nature of the individuals
receiving care. These contrasts are apparent between, for
example: DID studies using panel data to evaluate an inter-
vention such as CCT among individuals with CBA studies
of an intervention implemented at an organizational level
studying multiple cross-sections of health care episodes;
or credible and less credible interrupted time series.
There is a new article in the field of hospital epidemi-
ology which also highlights various features of what it terms
as quasi-experimental designs [56]. The list of features ap-
pears to be aimed at researchers designing a quasi-
experimental study, acting more as a prompt (e.g., ‘‘consider
options for .’’) rather than as a checklist for a researcher
appraising a study to communicate clearly to others about
the nature of a published study, which is our perspective
(e.g., a review author). There is some overlap with our
checklist, but the list described also includes several study
attributes intended to reduce the risk of bias, for example,
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risk of bias in a study is essential and needs to be carried out
as a separate task.5. Conclusion
The primary intention of the checklist is to help review
authors to set eligibility criteria for studies to include in a
review that relate directly to the intrinsic strength of the
studies in inferring causality. The checklist should also illu-
minate the debate between researchers in different fields
about the strength of studies with different featuresda
debate which has to date been somewhat obscured by the
use of different terminology by researchers working in
different fields of investigation. Furthermore, where dis-
agreements persist, the checklist should allow researchers
to inspect the basis for these differences, for example, the
principle through which researchers aimed to control for
confounding and shift their attention to clarifying the basis
for their respective responses for particular items.Acknowledgments
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